Electrospray-Mass Spectrometric Analysis of Plasma Pyrophosphates Separated on a Multi-Modal Liquid Chromatographic Column
- Electrospray-Mass Spectrometric Analysis of Plasma Pyrophosphates Separated on a Multi-Modal Liquid Chromatographic Column
- 이수현; 이정애; 이원용; 정봉철; 최만호
- Pyrophosphate; Isoprenoids; LC-MS; Multi-modal column; Statins; Cardiovascular disease
- Issue Date
- Mass Spectrometry Letters
- VOL 2, NO 4, 92-95
- Pyrophosphates are the key intermediates in the biosynthesis of isoprenoids, and their concentrations could reveal
the benefits of statins in cardiovascular diseases. Quantitative analysis of five pyrophosphates, including isopentenyl pyrophosphate
(IPP), dimethylallyl pyrophosphate (DMAPP), geranyl pyrophosphate (GPP), farnesyl pyrophosphate (FPP), and geranylgeranyl
pyrophosphate (GGPP), was performed using liquid chromatography-tandem mass spectrometry (LC-MS/MS) in negative ionization
mode. After dilution with methanol, samples were separated on a 3 μm particle multi-modal C18 column (50 × 2 mm)
and quantified within 10 min. The gradient elution consists of 10 mM ammonium bicarbonate and 0.5% triethylamine (TEA) in
water and 0.1% TEA in 80% acetonitrile was used at the flow rate of 0.4 mL/min. Overall recoveries were 51.4-106.6%, while
the limit of quantification was 0.05 μg/mL for GPP and FPP and 0.1 μg/mL for IPP, DMAPP, and GGPP. The precision (% CV)
and accuracy (% bias) of the assay were 1.9-12.3% and 89.6-111.8%, respectively, in 0.05-10 μg/mL calibration ranges (R2 > 0.993).
The devised LC-MS/MS technique with the multi-modal C18 column can be used to estimate the biological activity of pyrophosphates
in plasma and may be applicable to cardiovascular events with cholesterol metabolism as well as the drug efficacy of statins.
- Appears in Collections:
- KIST Publication > Article
- Files in This Item:
There are no files associated with this item.
- RIS (EndNote)
- XLS (Excel)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.